Obermatt
See Similar Stocks →

PepGen

NSQ:PEPG · US7133171055
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings3
Price/Book73
Dividend Yield1
Revenue Growth—
Profit Growth66
Capital Growth95
TSR 52w18
Leverage40
Liquidity63
Refinancing27
Combined—
Analyst Opinions32
Pro Holdings29
Opinion Changes50
Market Pulse53

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2020
Employees59
Websitepepgen.com
ISINUS7133171055
Last UpdateApr 2, 2026
Index & Theme
NeurologyCentral Nervous SystemNeuroscienceGenetic Disorder

Description

PepGen Inc. (PepGen) operates as a clinical-stage biotechnology company. The company is advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The co…

Similar Stocks

The companies this stock is ranked against.

Compare PepGen with its peers
Dyne Therapeutics
NSQ:DYN
34
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tharimmune
NAQ:THAR
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Assembly Biosciences
NSQ:ASMB
33
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Spyre Therapeutics
NSQ:SYRE
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Oric Pharmaceuticals
NSQ:ORIC
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nurix Therapeutics
NMQ:NRIX
18
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →